Cytalon (Cytarabine) 100mg/10ml

Cytalon (cytarabine) is an antineoplastic medication used in chemotherapy regimens. This 100mg/10ml solution is administered by healthcare professionals for cancer treatment. Always consult a physician before use. Short version: cytarabine 100mg/10ml solution for chemotherapy.

Strength

100mg/10ml

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cytalon (cytarabine) is primarily used to treat certain types of cancer, including leukemia and lymphoma. It works by interfering with cancer cell growth. Healthcare providers may use it alone or in combination with other medications. Patients often ask, what is cytarabine used for in cancer treatment? It is also used in high-dose regimens for specific conditions.

Side Effects

Cytalon (cytarabine) may cause temporary effects such as nausea or fatigue during treatment. Some patients experience changes in blood cell counts, which are monitored closely. Hair loss is a possible effect of chemotherapy. These effects vary by individual and treatment plan.

Precautions & Warnings

Cytalon (cytarabine) should only be handled and administered by trained healthcare professionals. Pregnant or breastfeeding individuals should avoid exposure. Protective equipment is recommended during preparation and administration. Avoid contact with skin or mucous membranes.

Avoid Interactions

Cytalon (cytarabine) may interact with other medications affecting bone marrow function. Drugs like certain antibiotics or immunosuppressants could increase side effects. Alcohol and herbal supplements should be avoided unless approved by a doctor. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Cytalon (cytarabine) is used to treat certain cancers, including leukemia and lymphoma, as part of chemotherapy regimens.

Cytalon is administered by healthcare professionals via injection or infusion, typically in a clinical setting.

Yes, common effects include nausea, fatigue, and changes in blood cell counts, which are monitored during treatment.

Cytalon should be avoided during pregnancy due to potential risks to the fetus; consult a doctor for alternatives.

Avoid alcohol, herbal supplements, and exposure to infections unless approved by your healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.